AU4685300A - Anticonvulsant derivatives useful in treating cocaine dependency - Google Patents

Anticonvulsant derivatives useful in treating cocaine dependency Download PDF

Info

Publication number
AU4685300A
AU4685300A AU46853/00A AU4685300A AU4685300A AU 4685300 A AU4685300 A AU 4685300A AU 46853/00 A AU46853/00 A AU 46853/00A AU 4685300 A AU4685300 A AU 4685300A AU 4685300 A AU4685300 A AU 4685300A
Authority
AU
Australia
Prior art keywords
formula
alkyl
compound
hydrogen
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46853/00A
Other languages
English (en)
Inventor
Richard P. Shank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU4685300A publication Critical patent/AU4685300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AU46853/00A 1999-04-30 2000-04-28 Anticonvulsant derivatives useful in treating cocaine dependency Abandoned AU4685300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13187799P 1999-04-30 1999-04-30
US60131877 1999-04-30
PCT/US2000/011722 WO2000066108A2 (en) 1999-04-30 2000-04-28 Anticonvulsant derivatives useful in treating cocaine dependency

Publications (1)

Publication Number Publication Date
AU4685300A true AU4685300A (en) 2000-11-17

Family

ID=22451401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46853/00A Abandoned AU4685300A (en) 1999-04-30 2000-04-28 Anticonvulsant derivatives useful in treating cocaine dependency

Country Status (6)

Country Link
EP (1) EP1175211A2 (de)
JP (1) JP2002543123A (de)
AU (1) AU4685300A (de)
CA (1) CA2372083A1 (de)
MX (1) MXPA01011014A (de)
WO (1) WO2000066108A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
BR0008477A (pt) 1999-02-24 2002-01-22 Univ Cincinnati Método para tratar um distúrbio de controle do impulso
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
WO2000066108A2 (en) 2000-11-09
JP2002543123A (ja) 2002-12-17
MXPA01011014A (es) 2003-06-30
EP1175211A2 (de) 2002-01-30
CA2372083A1 (en) 2000-11-09
WO2000066108A3 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
US6319903B1 (en) Anticonvulsant derivatives useful in treating cluster headaches
US6620819B2 (en) Anticonvulsant derivatives useful in treating psychosis
CA2369099C (en) Anticonvulsant derivatives useful in reducing blood glucose levels
AU774732B2 (en) Anticonvulsant derivatives useful in lowering lipids
US20020052325A1 (en) Anticonvulsant derivatives useful in maintaining weight loss
AU725570B2 (en) Anticonvulsant derivatives useful in treating neuropathic pain
WO2000042995A2 (en) Use of anticonvulsant derivatives for treating transformed migraine
AU759756B2 (en) Anticonvulsant derivatives useful in treating alcohol dependency, addiction and abuse
AU4685300A (en) Anticonvulsant derivatives useful in treating cocaine dependency
EP1148874B1 (de) Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
AU779823B2 (en) Anticonvulsant derivatives useful in treating essential tremor